ProCE Banner Series

Staying on Target: Reducing CV Risk by Achieving LDL-C Targets With Statin and Nonstatin Therapies

Join our esteemed faculty in this live symposium to hear the latest evidence on the comprehensive management of hyperlipidemia, including the importance of achieving LDL-C targets, addressing elevated Lp(a), optimally positioning all agents in the lipid armamentarium, and partnering with patients to reduce ASCVD risk.

This event is not part of the official Internal Medicine Meeting 2024 Education Program. CME credit is provided by organizations other than ACP.

  AAPA
  | AMA
  | ANCC
Who Should Attend

This program is intended for internal medicine physicians, nurse practitioners, physician associates, and other healthcare professionals who care for patients with hyperlipidemia.

All Events

Staying on Target: Reducing CV Risk by Achieving LDL-C Targets With Statin and Nonstatin Therapies

Past Events

April

19

2024

6:30 PM - 8:30 PM Eastern Time (ET)

In-person

The Westin Boston Seaport District, 425 Summer Street, Boston, Massachusetts 02210

7:00 PM - 8:30 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC

Medical Director
Center for Cardiovascular Analytics, Research, and Data Science (CARDS)
Providence Heart Institute
Providence Health System
Portland, Oregon

ProCE Banner Faculty
Michael Miller, MD, FACC, FAHA

Cardiologist & Professor of Medicine
Hospital of the University of Pennsylvania
Chief of Medicine
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania

Topics

Dyslipidemia, stroke

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Dyslipidemia.

Target Audience
This program is intended for internal medicine physicians, nurse practitioners, physician associates, and other healthcare professionals who care for patients with hyperlipidemia. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Compare and contrast LDL-C–lowering treatments to select the most appropriate agent for patients with hyperlipidemia
  • Incorporate effects of Lp(a) into risk assessment and treatment strategies for patients with or at risk for ASCVD
  • Implement evidence-based guideline recommendations for establishing and achieving LDL-C targets by appropriately initiating and intensifying therapy
  • Design individualized, optimized treatment regimens to help patients with hyperlipidemia reach LDL-C goals

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification 

Successful completion of this CME activity, which included participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Novartis Pharmaceuticals Corporation.